Drugs Made In America Acquisition DMII Cash Flow Statement (2025-2026)

NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT
Reported Financials

Drugs Made In America Acquisition Quarterly Cash Flow Statement

Periods 3 quarters
Latest Jun 2026

Drugs Made In America Acquisition cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 3 quarters of results from Sep 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2025 Dec2025 Jun2026
Operating Activities
Net Income -0.05M4.59M4.40M
Cash from Operations -0.69M-0.31M
Change in Working Capital
Change in Account Payables 0.00M0.09M
Change in Accured Expenses 0.08M
Misc.
Change in Cash 0.31M-0.31M
Free Cash Flow -0.69M-0.31M
Net Cash Flow -0.69M-0.31M

Drugs Made In America Acquisition Cash Flow Statement API

Pull Drugs Made In America Acquisition's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DMII&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY